Yorio T, Royce R, Mattern J, Oakford L X, Mia A J, Tarapoom N
Gen Pharmacol. 1985;16(4):347-53. doi: 10.1016/0306-3623(85)90194-6.
Phenothiazines and W7, calmodulin antagonists, inhibit the water flow response produced by ADH, exogenous cyclic AMP, phosphodiesterase inhibition and serosal hypertonicity. Calmodulin antagonists had no effect on osmotic water movement in the absence of hormone. Calmodulin was isolated and localized by immunofluorescence in bladder epithelial cells. Phenothiazines inhibited toad bladder calmodulin activation of phosphodiesterase and prevented fluorescent antibody recognition. The results suggest that the calcium-calmodulin process plays a role in the hydro-osmotic response to ADH and that produced by serosal hypertonicity. The calmodulin common site occurs subsequent to cyclic AMP formation, perhaps on the microtubule-microfilament system.
吩噻嗪类药物和W7(钙调蛋白拮抗剂)可抑制抗利尿激素(ADH)、外源性环磷酸腺苷(cAMP)、磷酸二酯酶抑制及浆膜高渗所产生的水流反应。在无激素的情况下,钙调蛋白拮抗剂对渗透性水运动无影响。通过免疫荧光法在膀胱上皮细胞中分离并定位了钙调蛋白。吩噻嗪类药物抑制蟾蜍膀胱钙调蛋白对磷酸二酯酶的激活,并阻止荧光抗体识别。结果表明,钙-钙调蛋白过程在对ADH的水渗透反应及浆膜高渗所产生的反应中起作用。钙调蛋白的共同作用位点在环磷酸腺苷形成之后出现,可能位于微管-微丝系统上。